pFA6-CFAPoptim-NAT
(Plasmid
#221129)
-
PurposePlasmid for generating integration cassette to C-terminally tag gene of interest with FAPoptim::NATMX
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 221129 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepFA6-NATMX4
-
Vector typeYeast Expression
-
Selectable markersnourseothricin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameFAPoptim
-
SpeciesS. cerevisiae (budding yeast)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Unknown (unknown if destroyed)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This FAPoptim integration plasmid was constructed by subcloning the FAPoptim sequence into the pFA6a-NATMX4 plasmid described in (Goldstein and McCusker, 1999). The resulting plasmid can be used for C-terminal tagging of endogenous protiens using the PCR-based integration strategy described in (Longtine et al., 1998).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pFA6-CFAPoptim-NAT was a gift from Allyson O’Donnell (Addgene plasmid # 221129 ; http://n2t.net/addgene:221129 ; RRID:Addgene_221129) -
For your References section:
Optimization of the fluorogen-activating protein tag for quantitative protein trafficking and colocalization studies in S. cerevisiae. Oppenheimer KG, Hager NA, McAtee CK, Filiztekin E, Shang C, Warnick JA, Bruchez MP, Brodsky JL, Prosser DC, Kwiatkowski AV, O'Donnell AF. Mol Biol Cell. 2024 Jul 1;35(7):mr5. doi: 10.1091/mbc.E24-04-0174. Epub 2024 May 29. 10.1091/mbc.E24-04-0174 PubMed 38809589